Five Years Later: Stefania Shares Lingering Effects after Treatment
It has been five years since my bone marrow transplant bone marrow transplant: A bone marrow transplant (BMT) is also called a stem cell transpla
Aplastic Anemia
Eltrombopag plus cyclosporine A for moderate aplastic anemia (EMAA): a placebo-controlled, double-blind, phase 3 trial
Original Publication Date
Article Source
External Web Content
Key Points In first-line therapy of MAA patients, CSA+eltrombopag significantly improves ORR at 24 weeks compared to CSA+placebo (71% vs. 43%; p=0.011) Addition of eltrombopag in patients without CR after 24 weeks of CSA therapy significantly improves ORR by week 48 (40% vs. 74%…
TA-TMA and GVHD are distinct consequences of endothelial injury: a MIDAS consortium study
Original Publication Date
Article Source
External Web Content
Key Points Posttransplant cyclophosphamide significantly reduced GVHD incidence but not TA-TMA incidence, which predated acute GVHD in ∼50% of cases. TA-TMA biomarker soluble C5b-9 was not significant in adults; pre-HCT serum creatinine, placental growth factor, and day +28 ST2…
Safety of Lowering the Platelet Transfusion Threshold Before Central Venous Catheterisation in Patients With Haematological Diseases
Original Publication Date
Article Source
External Web Content
ABSTRACT Introduction Central venous catheter (CVC) insertion is frequently required in patients with haematological diseases. Despite limited evidence, thrombocytopenia often prompts prophylactic platelet transfusion before catheterisation. Methods We conducted an observational…
Autologous stem cell transplantation in POEMS syndrome: Multicenter real-world treatment patterns and outcomes
Original Publication Date
Article Source
External Web Content
Abstract POEMS syndrome is a rare multisystem plasma cell disorder for which evidence guiding management is largely derived from single-center retrospective series. We conducted a retrospective multicenter study including all consecutive patients diagnosed between January 1995…
Patient and Caregiver Involvement With Prior Authorization and Care Delivery and Delays
Original Publication Date
Article Source
External Web Content
Introduction Payers employ health care utilization–management strategies, including prior authorization (PA), to limit costs and promote evidence-based, guideline-concordant care. However, PA may be inconsistently applied and associated with patient confusion and frustration.1-3…
Getting the Right Diagnosis, from the 2026 AAMDSIF New Brunswick Patient and Family Conference
Topic(s)
Aplastic Anemia
Myelodysplastic Syndromes (MDS)
Paroxysmal Nocturnal Hemoglobinuria (PNH)
Dr. Virian Serei discusses how bone marrow failure is diagnosed, including the tests and evaluations used to receive a diagnosis of of aplastic anemia, myelodysplastic syndromes (MDS), or paroxysmal nocturnal hemoglobinuria (PNH).
Is a Transplant Right for Me? Session from the 2026 AAMDSIF New Brunswick Patient-Family Conference
Topic(s)
Aplastic Anemia
Bone Marrow Transplant
Myelodysplastic Syndromes (MDS)
Paroxysmal Nocturnal Hemoglobinuria (PNH)
Presenter(s)
Srinivasa Reddy Sanikommu, MD
Dr. Srinivasa Samikommu discusses bone marrow transplant, the transplant process, how doctors determine if it may be right for a patient and what you as a patient need to consider before moving forward with a transplant. The session was recorded at the 2026 AAMDSIF New Brunswick…
2026 Houston Patient and Family Conference
CONFERENCE AGENDA - November 7, 2026
8:00 - 2:45 (Central Time Zone)